| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5303574 | A | The drug is tested on Bifidobacterium adolescentis strain: ATCC 15703 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bifidobacterium adolescentis | 247 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 2. | ALA5303575 | A | The drug is tested on Bifidobacterium breve strain: DSM20213 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bifidobacterium breve | 225 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 3. | ALA5303576 | A | The drug is tested on Bifidobacterium longum subsp. Infantis strain: CCUG52486 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bifidobacterium longum subsp. Infantis | 243 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 4. | ALA5303577 | A | The drug is tested on Bifidobacterium ruminantium strain: fecal isolate for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bifidobacterium ruminantium | 208 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 5. | ALA5303578 | A | The drug is tested on Collinsella aerofaciens strain: ATCC25986 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Collinsella aerofaciens | 258 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 6. | ALA5303579 | A | The drug is tested on Collinsella intestinalis strain: DSM13280 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Collinsella intestinalis | 254 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 7. | ALA5303580 | A | The drug is tested on Eggerthella lenta strain: ATCC25559 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Eggerthella lenta | 152 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 8. | ALA5303581 | A | The drug is tested on Alistipes indistinctus strain: DSM22520 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Alistipes indistinctus | 202 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 9. | ALA5303583 | A | The drug is tested on Bacteroides cellulosilyticus strain: DSM14838 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides cellulosilyticus | 196 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 10. | ALA5303584 | A | The drug is tested on Bacteroides coprophilus strain: DSM18228 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides coprophilus | 227 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 11. | ALA5303585 | A | The drug is tested on Bacteroides dorei strain: DSM17855 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Phocaeicola dorei | 223 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 12. | ALA5303586 | A | The drug is tested on Bacteroides eggerthii strain: DSM20697 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides eggerthii | 244 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 13. | ALA5303587 | A | The drug is tested on Bacteroides finegoldii strain: DSM17565 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides finegoldii | 238 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 14. | ALA5303588 | A | The drug is tested on Bacteroides fragilis strain: NCTC 9343 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides fragilis | 234 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 15. | ALA5303589 | A | The drug is tested on Bacteroides fragilis strain: 3397 (T10) for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides fragilis | 229 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 16. | ALA5303590 | A | The drug is tested on Bacteroides fragilis strain: T(B)9 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides fragilis | 217 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 17. | ALA5303591 | A | The drug is tested on Bacteroides fragilis strain: DS-208 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides fragilis | 235 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 18. | ALA5303592 | A | The drug is tested on Bacteroides fragilis strain: HMW610 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides fragilis | 216 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 19. | ALA5303593 | A | The drug is tested on Bacteroides fragilis strain: HMW615 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides fragilis | 205 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 | |
| 20. | ALA5303594 | A | The drug is tested on Bacteroides fragilis strain: ATCC43859 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS) | Bacteroides fragilis | 202 | ALA5303573 | assay format | Zimmerman Lab Biotransformation data Dec 2023 |
The page will load shortly, Thanks for your patience!